Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1983 1
1984 2
1985 5
1986 6
1987 4
1988 4
1989 6
1990 10
1991 5
1993 4
1994 4
1995 7
1996 11
1997 9
1998 12
1999 16
2000 11
2001 13
2002 6
2003 13
2004 4
2005 17
2006 10
2007 14
2008 13
2009 18
2010 16
2011 11
2012 22
2013 21
2014 16
2015 14
2016 21
2017 11
2018 20
2019 24
2020 22
2021 20
2022 13
2023 14
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

423 results

Results by year

Filters applied: . Clear all
Page 1
Behçet's syndrome.
Emmi G, Bettiol A, Hatemi G, Prisco D. Emmi G, et al. Among authors: prisco d. Lancet. 2024 Mar 16;403(10431):1093-1108. doi: 10.1016/S0140-6736(23)02629-6. Epub 2024 Feb 22. Lancet. 2024. PMID: 38402885 Review.
Factor XI inhibitors: cardiovascular perspectives.
De Caterina R, Prisco D, Eikelboom JW. De Caterina R, et al. Among authors: prisco d. Eur Heart J. 2023 Jan 21;44(4):280-292. doi: 10.1093/eurheartj/ehac464. Eur Heart J. 2023. PMID: 36263776 Review.
Vascular Behçet syndrome: from pathogenesis to treatment.
Bettiol A, Alibaz-Oner F, Direskeneli H, Hatemi G, Saadoun D, Seyahi E, Prisco D, Emmi G. Bettiol A, et al. Among authors: prisco d. Nat Rev Rheumatol. 2023 Feb;19(2):111-126. doi: 10.1038/s41584-022-00880-7. Epub 2022 Dec 21. Nat Rev Rheumatol. 2023. PMID: 36544027 Review.
Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.
Pengo V, Denas G, Zoppellaro G, Jose SP, Hoxha A, Ruffatti A, Andreoli L, Tincani A, Cenci C, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Banzato A. Pengo V, et al. Among authors: prisco d. Blood. 2018 Sep 27;132(13):1365-1371. doi: 10.1182/blood-2018-04-848333. Epub 2018 Jul 12. Blood. 2018. PMID: 30002145 Free article. Clinical Trial.
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.
Bettiol A, Urban ML, Dagna L, Cottin V, Franceschini F, Del Giacco S, Schiavon F, Neumann T, Lopalco G, Novikov P, Baldini C, Lombardi C, Berti A, Alberici F, Folci M, Negrini S, Sinico RA, Quartuccio L, Lunardi C, Parronchi P, Moosig F, Espígol-Frigolé G, Schroeder J, Kernder AL, Monti S, Silvagni E, Crimi C, Cinetto F, Fraticelli P, Roccatello D, Vacca A, Mohammad AJ, Hellmich B, Samson M, Bargagli E, Cohen Tervaert JW, Ribi C, Fiori D, Bello F, Fagni F, Moroni L, Ramirez GA, Nasser M, Marvisi C, Toniati P, Firinu D, Padoan R, Egan A, Seeliger B, Iannone F, Salvarani C, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Bettiol A, et al. Among authors: prisco d. Arthritis Rheumatol. 2022 Feb;74(2):295-306. doi: 10.1002/art.41943. Epub 2021 Dec 30. Arthritis Rheumatol. 2022. PMID: 34347947 Free PMC article.
Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.
Bettiol A, Urban ML, Bello F, Fiori D, Mattioli I, Lopalco G, Iannone F, Egan A, Dagna L, Caminati M, Negrini S, Bargagli E, Folci M, Franceschini F, Padoan R, Flossmann O, Solans R, Schroeder J, André M, Moi L, Parronchi P, Roccatello D, Sciascia S, Jayne D, Prisco D, Vaglio A, Emmi G; European EGPA Study Group. Bettiol A, et al. Among authors: prisco d. Ann Rheum Dis. 2022 Dec;81(12):1769-1772. doi: 10.1136/ard-2022-222776. Epub 2022 Jul 18. Ann Rheum Dis. 2022. PMID: 35850947 No abstract available.
Behçet: the syndrome.
Bettiol A, Prisco D, Emmi G. Bettiol A, et al. Among authors: prisco d. Rheumatology (Oxford). 2020 May 1;59(Suppl 3):iii101-iii107. doi: 10.1093/rheumatology/kez626. Rheumatology (Oxford). 2020. PMID: 32348523 Review.
SIRT1 and thrombosis.
Bettiol A, Urban ML, Emmi G, Galora S, Argento FR, Fini E, Borghi S, Bagni G, Mattioli I, Prisco D, Fiorillo C, Becatti M. Bettiol A, et al. Among authors: prisco d. Front Mol Biosci. 2024 Jan 18;10:1325002. doi: 10.3389/fmolb.2023.1325002. eCollection 2023. Front Mol Biosci. 2024. PMID: 38304233 Free PMC article. Review.
Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two-year outcomes after the study closure.
Pengo V, Hoxha A, Andreoli L, Tincani A, Silvestri E, Prisco D, Fierro T, Gresele P, Cafolla A, De Micheli V, Ghirarduzzi A, Tosetto A, Falanga A, Martinelli I, Testa S, Barcellona D, Gerosa M, Denas G. Pengo V, et al. Among authors: prisco d. J Thromb Haemost. 2021 Feb;19(2):531-535. doi: 10.1111/jth.15158. Epub 2020 Nov 29. J Thromb Haemost. 2021. PMID: 33128325 Free article. Clinical Trial.
Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.
Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y. Imazio M, et al. Among authors: prisco d. Eur J Prev Cardiol. 2020 Jun;27(9):956-964. doi: 10.1177/2047487319879534. Epub 2019 Oct 15. Eur J Prev Cardiol. 2020. PMID: 31610707 Free article.
423 results